Aprea Therapeutics, Inc. (APRE)
0.8052
+0.16
(+25.75%)
USD |
NASDAQ |
Aug 24, 16:00
0.75
-0.06
(-6.86%)
After-Hours: 20:00
Aprea Therapeutics Shareholders Equity (Quarterly) : 39.20M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.20M |
| March 31, 2026 | 42.82M |
| December 31, 2025 | 13.17M |
| September 30, 2025 | 11.64M |
| June 30, 2025 | 14.14M |
| March 31, 2025 | 16.86M |
| December 31, 2024 | 20.62M |
| September 30, 2024 | 23.26M |
| June 30, 2024 | 26.87M |
| March 31, 2024 | 30.23M |
| December 31, 2023 | 18.26M |
| September 30, 2023 | 21.60M |
| June 30, 2023 | 24.73M |
| March 31, 2023 | 27.79M |
| Date | Value |
|---|---|
| December 31, 2022 | 26.95M |
| September 30, 2022 | 26.63M |
| June 30, 2022 | 33.00M |
| March 31, 2022 | 43.59M |
| December 31, 2021 | 49.51M |
| September 30, 2021 | 53.42M |
| June 30, 2021 | 60.95M |
| March 31, 2021 | 69.15M |
| December 31, 2020 | 77.40M |
| September 30, 2020 | 89.02M |
| June 30, 2020 | 100.12M |
| March 31, 2020 | 113.35M |
| December 31, 2019 | 124.24M |
| September 30, 2019 | 47.39M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zymeworks, Inc. | 80.37M |
| Rhythm Pharmaceuticals, Inc. | 217.30M |
| Onconetix, Inc. | 13.47M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 42.29M |
| Total Liabilities (Quarterly) | 3.092M |
| Current Ratio | 13.55 |